Pancreatic cancer, which is the fifth most common cause of cancer death in the UK, can lead to a condition known as deep vein ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

So what is semaglutide and who uses it in India? Semaglutide belongs to the class of drugs called Glucagon-like peptide-1 ...

Obesity caused by a lifestyle of moving less and eating more is a prime factor contributing to Type 2 diabetes. Is the answer ...

This all-encompassing guide investigates the smart insulin pen and its influence on diabetes management. Here's what you need ...

Nearly 16% of American adults -- that's close to 1 in 6 -- now has diabetes, according to the latest data from the U.S.

Ever since their rise in popularity as weight loss drugs, there’s been a slew of reports on the potential ... which are ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason for the sharp ...

However, in the face of a lawsuit brought by compounders, the FDA decided that they can continue to make copies of Zepbound and Mounjaro while the agency reevaluates whether there is sufficient supply ...

Analysts have struggled to estimate the size of the compounded market for weight-loss drugs because their sale is not tracked ...